Teva Pharmaceuticals (NYSE: TEVA)
Special Situations: Brent Saunders Interview
August 8, 2017
In an interview with Jim Cramer last night, Allergan (NYSE: AGN) CEO Brent Saunders had the following to say with regard to AGN’s 10% stake in TEVA:
“…we’re responsible stewards. We will sell the stock over the next few quarters in a very responsible way. We’re not going to be long term into TEVA.
“But I’m not sure selling at this price is the right price, either.”
So while obviously this represents a multi-quarter overhang, IMO this comment should stem the immediate panic.